NDC 0169-1912 – Zegalogue

Dasiglucagon .6 mg/.6mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC0169-1912

Product details

Brand name
Zegalogue
Generic name
Dasiglucagon
Labeler
Novo Nordisk
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
NDA · NDA214231
Marketed since
June 26, 2023
Marketing end
August 31, 2027
Pharmacologic class
Antihypoglycemic Agent

Active ingredients

Uses, dosage, side effects and warnings for Zegalogue →

Package NDC codes (2)

Package NDCDescriptionSince
0169-1912-011 CONTAINER in 1 PACKAGE (0169-1912-01) / 1 SYRINGE, GLASS in 1 CONTAINER / .6 mL in 1 SYRINGE, GLASSJun 26, 2023
0169-1912-022 PACKAGE in 1 CARTON (0169-1912-02) / 1 CONTAINER in 1 PACKAGE (0169-1912-12) / 1 SYRINGE, GLASS in 1 CONTAINER / .6 mL in 1 SYRINGE, GLASSJun 26, 2023

Other Zegalogue products